Literature DB >> 9925081

The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study.

P E Marik1, P Careau.   

Abstract

CONTEXT: Aspiration of oropharyngeal material, with its high concentration of anaerobic bacteria, has been implicated in the pathogenesis of both ventilator-associated pneumonia (VAP) and aspiration pneumonitis (AP). Consequently, patients with these disorders are usually treated with antimicrobial agents with anaerobic activity.
OBJECTIVE: To determine the incidence of anaerobic bacteria in patients with VAP and AP.
DESIGN: Prospective, nonrandomized, interventional study.
SETTING: University-affiliated community teaching hospital. PATIENTS AND
INTERVENTIONS: We performed sequential blind protected specimen brush (PSB) sampling and mini-BAL in 143 patients with 185 episodes of suspected VAP and 25 patients with AP who required mechanical ventilation. Quantitative aerobic and anaerobic cultures were performed on all specimens. Pneumonia was considered to be present when either > 500 cfu/mL cultured from blind PSB sampling or > 5,000 cfu/mL cultured from mini-BAL were present.
RESULTS: Using the predefined criteria, bacterial pneumonia was diagnosed in 63 of 185 suspected VAP episodes (34%) and 12 of 25 patients with AP (48%). At least one dose of an antibiotic was given in the 24 h prior to bacteriologic sampling in 106 suspected VAP episodes (57%) and in 12 patients with AP (48%). More than one pathogen was isolated from 11 VAP and four AP patients. Pseudomonas aeruginosa, Staphylococcus aureus, and enteric Gram-negative organisms were isolated most frequently from patients with VAP. In the patients with AP, enteric Gram-negative organisms were isolated in patients with GI disorders and Streptococcus pneumoniae and Haemophilus influenzae predominated in patients with "community-acquired" aspiration. Only one anaerobic organism was isolated from the entire group of patients; Veillonella paravula was isolated from a blind PSB specimen in a patient with suspected aspiration pneumonia.
CONCLUSION: Despite painstaking effort, we were able to isolate only one anaerobic organism (nonpathogenic) from this group of patients. The spectrum of aerobes in patients with VAP was similar to that reported in the literature. The organisms found in patients with AP was a reflection of the organisms likely to colonize the oropharynx. The use of antibiotics with anaerobic coverage may not be necessary in patients with suspected VAP and AP. Furthermore, penicillin G and clindamycin may not be the antibiotics of choice in patients with AP.

Entities:  

Mesh:

Year:  1999        PMID: 9925081     DOI: 10.1378/chest.115.1.178

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  30 in total

1.  Anaerobic Infections of the Lung.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

2.  Aliens, anaerobes, and the lung!

Authors:  Paul Marik
Journal:  Intensive Care Med       Date:  2003-07       Impact factor: 17.440

3.  Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.

Authors:  Jien-Wei Liu; Yen-Hsu Chen; Wen-Sen Lee; Jung-Chung Lin; Ching-Tai Huang; Hsi-Hsun Lin; Yung-Ching Liu; Yin-Ching Chuang; Hung-Jen Tang; Yao-Shen Chen; Wen-Chien Ko; Min-Chi Lu; Fu-Der Wang
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

4.  Protected telescopic catheter also allows anaerobic bacteria isolation in patients with ventilatory-acquired pneumonia.

Authors:  René Robert; Hodanou Nanadoumgar; Delphine Chatellier; Anne Veinstein; Jean-Pierre Frat; Ghislaine Grollier
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

5.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

6.  Pre-hospital intubation factors and pneumonia in trauma patients.

Authors:  Heather L Evans; Keir Warner; Eileen M Bulger; Sam R Sharar; Ronald V Maier; Joseph Cuschieri
Journal:  Surg Infect (Larchmt)       Date:  2011-09-20       Impact factor: 2.150

Review 7.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 8.  Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".

Authors:  Alberto Sandiumenge; Emili Diaz; Maria Bodí; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-04-02       Impact factor: 17.440

9.  Translocation and dissemination of commensal bacteria in post-stroke infection.

Authors:  Dragana Stanley; Linda J Mason; Kate E Mackin; Yogitha N Srikhanta; Dena Lyras; Monica D Prakash; Kulmira Nurgali; Andres Venegas; Michael D Hill; Robert J Moore; Connie H Y Wong
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440

10.  Role of pathogenic oral flora in postoperative pneumonia following brain surgery.

Authors:  Kinga Bágyi; Angela Haczku; Ildikó Márton; Judit Szabó; Attila Gáspár; Melinda Andrási; Imre Varga; Judit Tóth; Almos Klekner
Journal:  BMC Infect Dis       Date:  2009-06-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.